Pomaglumetad methionil: no significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo (Q34371074)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pomaglumetad methionil: no significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo |
scientific article |
Statements
1 reference
Pomaglumetad methionil: no significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo (English)
1 reference
Virginia L Stauffer
1 reference
Brian A Millen
1 reference
Scott Andersen
1 reference
Bruce J Kinon
1 reference
Lisa Lagrandeur
1 reference
J P Lindenmayer
1 reference
Juan Carlos Gomez
1 reference
12 September 2013
1 reference
1 reference
Identifiers
1 reference